We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Fig. 2

Fig. 2. From: Overexpression of COX-2 in Rat Oral Cancers and Prevention of Oral Carcinogenesis in Rats by Selective and Non-Selective COX Inhibitors.

Survival in carcinogen-treated rats fed control diet or diets supplemented with celecoxib, piroxicam, or zileuton.

David L. McCormick, et al. Cancer Prev Res (Phila). ;3(1):73-81.
2.
Fig. 3

Fig. 3. From: Overexpression of COX-2 in Rat Oral Cancers and Prevention of Oral Carcinogenesis in Rats by Selective and Non-Selective COX Inhibitors.

Group mean body weight in carcinogen-treated rats fed control diet or diets supplemented with celecoxib, piroxicam, or zileuton.

David L. McCormick, et al. Cancer Prev Res (Phila). ;3(1):73-81.
3.
Fig. 1

Fig. 1. From: Overexpression of COX-2 in Rat Oral Cancers and Prevention of Oral Carcinogenesis in Rats by Selective and Non-Selective COX Inhibitors.

Comparative expression of COX-2 in paired sets of oral tissues (squamous cell carcinomas and adjacent phenotypically normal tissue) harvested from ten NQO-treated rats. COX-2 is overexpressed in 9 of 10 oral cancers, with level of overexpression ranging from 12-fold to 22-fold in comparison to adjacent normal tissue harvested from the same rat.

David L. McCormick, et al. Cancer Prev Res (Phila). ;3(1):73-81.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk